Latest Breaking News On - Directors effective january - Page 1 : comparemela.com

Finning reports Q3 2023 results

VANCOUVER, British Columbia, Nov. 06, 2023 (GLOBE NEWSWIRE) Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”).

United statesBritish columbiaUnited kingdomEnergystbv energystIlona rojkovaKevin parkesHarold kvisleJohn rhindShell canada ltdSyncrude canada ltdInternational incHydraquip hose hydraulics ltdEnergy safety canadaSouth americaDirectors effective januaryChief executive

Finning reports Q3 2023 results - The Globe and Mail

Detailed price information for Finning Intl (FTT-T) from The Globe and Mail including charting and trades.

United statesBritish columbiaUnited kingdomIlona rojkovaJohn rhindEnergystbv energystKevin parkesHarold kvisleEnergy safety canadaInternational incSyncrude canada ltdHydraquip hose hydraulics ltdShell canada ltdSouth americaDirectors effective januaryChief executive

Finning reports Q3 2023 results

Finning reports Q3 2023 results
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomEnergystbv energystJohn rhindIlona rojkovaHarold kvisleKevin parkesInternational incShell canada ltdHydraquip hose hydraulics ltdEnergy safety canadaSyncrude canada ltdSouth americaDirectors effective januaryChief executive

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

Bioventus Appoints Michelle McMurry-Heath to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJoseph liebermanWilliam hawkinsMichelle mcmurry heathUniversity of californiaCompany on linkedinSociety scholarRadiological healthRobert wood johnson healthBioventus incCompany quarterly report on formInternational clinical evidenceAspen instituteCompany board of directorsRegulatory affairs